EBR Systems (ASX: EBR) Slumps to New Lows as Capital Raise Sparks Investor Exit
Jun 6, 2026
Proactive Equities Team
EBR Systems has fallen sharply after a major capital raise sparked dilution concerns. Despite the sell-off, the company continues to expand the commercialisation of its FDA-approved WiSE CRT heart-failure technology, supported by growing implant volumes, clinical studies, and international regulatory progress.
